Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial
“…Overall, we found that discrepancies in CNV detection can be accounted to more sensitive detection of abnormalities in CBA due to a proliferative advantage of the abnormal clone and due to smaller clone sizes in PB compared to BM supported by mutational analysis. In cases with large differences in clone size between BM and PB CD34-enriched PB samples might help to overcome these limitations [ 6 – 8 ]. …”
“…Overall, we found that discrepancies in CNV detection can be accounted to more sensitive detection of abnormalities in CBA due to a proliferative advantage of the abnormal clone and due to smaller clone sizes in PB compared to BM supported by mutational analysis. In cases with large differences in clone size between BM and PB CD34-enriched PB samples might help to overcome these limitations [ 6 – 8 ]. …”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.